![]() |
|
|
Vol. 287, Issue 2, 800-805, November 1998
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
| |
Abstract |
|---|
|
|
|---|
We have isolated a kidney-specific organic cation transporter, rat OCT2, which is distinct from rat OCT1 (Okuda M, Saito H, Urakami Y, Takano M and Inui K (1996) Biochem Biophys Res Commun 224:500-507). In our study, the functional characteristics and membrane localization of OCT1 and OCT2 were investigated by uptake studies using MDCK cells transfected with rat OCT1 or OCT2 cDNA (MDCK-OCT1 or MDCK-OCT2) and immunological studies. Tetraethylammonium (TEA) uptake by both MDCK-OCT1 and MDCK-OCT2 cells was markedly elevated when TEA was added to the basolateral medium, but not to the apical medium. Efflux of TEA from MDCK-OCT1 and MDCK-OCT2 cells was not changed by extracellular pH from 5.4 to 8.4, whereas TEA uptake by both transfectants was decreased by acidification of extracellular medium. Apparent Km values for TEA uptake by MDCK-OCT1 and MDCK-OCT2 cells were 38 and 45 µM, respectively. Although various hydrophilic organic cations such as 1-methyl-4-phenylpyridinium, cimetidine, quinidine, nicotine, N1-methylnicotinamide and guanidine markedly inhibited TEA uptake by both MDCK-OCT1 and MDCK-OCT2 cells, there were no significant differences in the apparent inhibition constants (Ki) against these organic cations between both transfectants. Furthermore, immunological studies using a polyclonal antibody against OCT1 revealed that OCT1 was expressed in the basolateral membranes but not in the brush-border membranes of the rat kidney. These results suggested that both OCT1 and OCT2 are basolateral-type organic cation transporters with broad substrate specificities, mediating tubular secretion of cationic drugs.
| |
Introduction |
|---|
|
|
|---|
Tubular
secretion of various structurally unrelated organic cations including
xenobiotics and endogenous compounds is critical for the maintenance of
body fluid homeostasis and the defense of the body against toxic
reactions. In general, the sequence of tubular secretion of organic
cations is described as basolateral uptake, accumulation into the cell
and subsequent extrusion from the cell into tubular fluid across
brush-border membranes of renal epithelial cells (Inui et
al., 1991
; Pritchard and Miller, 1993
). Using membrane vesicles
isolated from rat (Takano et al., 1984
), dog (Holohan and
Ross, 1981
) or rabbit (Hsyu and Giacomini, 1987
; Dantzler et
al., 1989
; Montrose-Rafizadeh et al., 1989
; Sokol and
McKinney, 1990
) kidneys and cultured epithelial cells derived from the
pig kidney (Saito et al., 1992
), it became clear that basolateral and brush-border transport systems for organic cations are
driven by different forces; i.e., basolateral uptake is
stimulated by the inside-negative membrane potential, whereas extrusive
transport across brush-border membranes is stimulated by the opposite
proton gradient. However, it is speculated that there are multiple
transport systems for organic cations in the kidney (Miyamoto et
al., 1989
). Gründemann et al. (1994)
isolated a
rat organic cation transporter, OCT1, which is predominantly expressed
in the liver and kidney. We postulated the presence of another member
of the organic cation transporter family, and then screened a rat
kidney cDNA library using a cDNA fragment encoding rat OCT1. A cDNA
encoding an organic cation transporter distinct from OCT1 that we named
rat OCT2 was isolated (Okuda et al., 1996
). Rat OCT2 is
homologous (67%) to rat OCT1, but its message is exclusively expressed
in the kidney. However, little is known about the functional
characteristics and membrane localization (basolateral or brush-border)
of rat OCT1 and OCT2. In this study, we established epithelial cell
lines stably expressing rat OCT1 or OCT2 and compared their transport characteristics. Our results showed that both OCT1 and OCT2 are organic
cation transporters with characteristics comparable to basolateral
organic cation transporters in renal tubular cells. In addition, rat
OCT1 protein was shown to be expressed in the basolateral membranes but
not in the brush-border membranes of rat kidney using a polyclonal
antibody raised against rat OCT1 polypeptide.
| |
Methods |
|---|
|
|
|---|
Cell culture and transfection.
The parental MDCK cells (ATCC
CCL-34) obtained from American Type Culture Collection
(Manassas, VA) were cultured in complete medium consisting of
Dulbecco's modified Eagle's medium (Life Technologies, Inc.,
Rockville, MD) with 10% fetal calf serum (Whittaker Bioproducts Inc.,
Walkersville, MD) in an atmosphere of 5% CO2, 95% air at
37°C. OCT1 cDNA was subcloned into the SalI- and
NotI-cut mammalian expression vector pBK-CMV (Stratagene, La
Jolla, CA) (Brewer, 1994
). The open reading frame of OCT2 cDNA was
amplified by PCR using a set of specific primers for the nucleotide
sequence of rat OCT2 (sense strand with a PstI site,
5'-CCCTGCAGAGGGACCATGTCGACCGTGGATGA-3' (bases
7-17); antisense
strand with a NotI site,
5'-CCGCGGCCGCAGTTCAGGGGTAAGTGAGGTTGGTT-3' (bases 1,761-1,785)), and
then subcloned into PstI- and NotI-cut pBK-CMV.
The nucleotide sequence of the subcloned cDNA insert was determined
using a fluorescence DNA sequencer 373A (Applied Biosystems, Foster
City, CA) and confirmed to be identical to the corresponding
sequence of OCT2. MDCK cells were transfected with pBK-CMV/OCT1,
pBK-CMV/OCT2 or pBK-CMV using the calcium phosphate coprecipitation
technique as described previously (Terada et al., 1996
).
Fifteen hours after transfection, cells were rinsed with Ca++- and Mg++-free Dulbecco's
phosphate-buffered saline (pH 7.4) (PBS(
) comprised of 137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, and 1.5 mM
KH2PO4) containing 15% glycerol for 1 min, and
then cultured under normal conditions. Forty-eight hours later, the
cells split between 1:1 and 1:12 were cultured in complete medium
containing G418 (0.5 mg/ml) (Life Technologies, Inc.). Then 7 to 14 days after transfection, single colonies appeared and several colonies
were picked up based on the growth rate and morphology of the cells.
G418-resistant clonal cells were analyzed by RT-PCR for the expression
of rat OCT1 and OCT2 mRNAs. For the uptake experiments, cells were
seeded on microporous membrane filters [3.0-µm pores, 4.71 (or 1.0)
cm2 growth area] inside a Transwell cell culture chamber
(Costar, Cambridge, MA) at a cell density of 5 × 105
cells/cm2 with complete medium, as described previously
(Saito et al., 1992
). In this study, MDCK cells were used
between the 81st and 91st passages.
RT-PCR analysis.
Total RNA was extracted from rat tissues
and MDCK transfectants by the guanidium/isothiocyanate method (Chirgwin
et al., 1979
) or using RNeasy spin columns (Qiagen GmbH,
Hilden, Germany), respectively. For RT-PCR analysis, 5 µg of total
RNA from each tissue and MDCK transfectants were reverse-transcribed
using Superscript II (Life Technologies, Inc.) and amplified with sets
of specific primers for either rat OCT1 [sense strand,
5'-CAGAAGAACGGGAAGGTGCC-3' (bases 922-941); antisense strand,
5'-TACAAGAGTCTGGAAAGGCA-3' (bases 1,746-1,765)] or rat OCT2 [sense
strand, 5'-ACCTTCAATCCTGGACTTGG-3' (bases 996-1,015); antisense
strand, 5'-CAACCAGTGGGAACTCCAT-3' (bases 1,477-1,495)].
Uptake study.
Uptake of
[14C]tetraethylammonium by the cells was measured using
monolayer cultures grown in Transwell chambers. The incubation medium
for uptake experiments contained 145 mM NaCl, 3 mM KCl, 1 mM
CaCl2, 0.5 mM MgCl2, 5 mM D-glucose
and 5 mM MES (pH 5.4 and 6.4) or 5 mM HEPES (pH 7.4 and 8.4). The pH of
the medium was adjusted with NaOH or HCl. After removing the culture
medium from both sides of the monolayers, the cells were washed once with 2 ml of incubation medium (pH 7.4) in each side for the
4.71-cm2 chamber (1 ml for the 1.0-cm2 chamber)
and then incubated for 10 min at 37°C with 2 ml of the same medium in
each side (apical 0.5 ml and basolateral 1 ml for the
1.0-cm2 chamber). This was replaced with 2 ml of incubation
medium containing [14C]tetraethylammonium in either the
apical or basolateral side (1 ml in the basolateral side for the
1.0-cm2 chamber) and the cells were incubated at 37°C.
Unlabeled incubation medium was added to the opposite side. The medium
was immediately aspirated off and the culture inserts were rapidly
rinsed twice with 2 ml of ice-cold incubation medium (pH 7.4) in each
side (1 ml each for the 1.0-cm2 chamber). For the efflux
experiments, cell monolayers grown on the 4.71-cm2 chambers
were incubated with 2 ml of incubation medium containing 50 µM
[14C]tetraethylammonium for 15 min from the basolateral
side. After incubation, the cells were rinsed twice with 2 ml of
incubation medium (pH 7.4) in each side, and then incubated with 2 ml
of unlabeled incubation medium (pH 5.4-8.4 for the basolateral side and pH 7.4 for the apical side) for 5 min. The cells were lysed with 1 N NaOH, and then the radioactivity in aliquots was determined in 5 ml
of ACSII (Amersham International, Buckinghamshire, UK) by liquid
scintillation counting. The amount of protein in the solubilized cell
monolayers was determined by the method of Bradford (1976)
, using a
Bio-Rad Protein Assay kit (Bio-Rad Laboratories, Hercules, CA) with
bovine
-globulin as a standard.
Polyclonal antibody against OCT1.
According to our previous
reports (Saito et al., 1995
; Masuda et al.,
1997
), polyclonal antibodies were raised against a synthetic peptide
corresponding to the intracellular domains of the COOH-terminal of rat
OCT1 (YLQVQTGKSSST). The peptide was synthesized with cysteine at its
NH2-terminal; the purity of the peptide was shown to be 96.5% by high-performance liquid chromatography (Peptide Institute, Osaka, Japan). After obtaining preimmune serum, rabbit antiserum was
raised against the peptide conjugated to keyhole limpet hemocyanin. A
male New Zealand White rabbit (2.5 kg) was immunized with 1 ml of
conjugates (1 mg of the peptide) emulsified with Freund's complete
adjuvant. The emulsified conjugates were injected as boosters every 2 wk until the antibody was obtained. After each booster injection, blood
was collected and antibody production was determined by enzyme-linked
immunosorbent assay. We also tried to raise an anti-OCT2 antibody, but
we could not obtain the antibody with sufficient titer.
Affinity purification of antibody and Western blotting
analysis.
The antiserum used for Western blotting analysis was
purified by immunoadsorption on polyvinylidene difluoride membrane
(Immobilon-P; Millipore, Bedford, MA) strips according to the method
reported by Sabolic et al. (1992)
with some modifications.
The synthetic antigen peptides were separated by 15% SDS-PAGE and
transferred onto Immobilon-P membranes by semi-dry electroblotting for
30 min. A horizontal strip of membrane containing the peptide was confirmed by Western blotting, excised, washed with Tris-buffered saline containing Tween 20 (TBS-T, 20 mM Tris-HCl, 137 mM NaCl, 0.1%
Tween 20, pH 7.5), and then incubated with the immune serum for 4 hr at
25°C to adsorb anti-OCT1 antibody. The strips were then washed with
TBS-T buffer, and the immunoaffinity-adsorbed antibody was released by
incubation in 0.1 M citrate buffer (pH 2.0) for 1 min with constant
mixing, followed by neutralization to pH 7.4 with 1 M Tris-HCl buffer
(pH 10.5). The affinity-purified anti-OCT1 antibody was diluted 1:10
for Western blotting.
-mercaptoethanol. The samples were separated by 10% SDS-PAGE and transferred onto Immobilon-P membranes by semi-dry electroblotting for 30 min. The blots were incubated with purified antiserum
preabsorbed with the synthetic antigen peptide (1.0 µg/ml) or the
primary purified antibody (1:10) for 2 hr at 25°C. Blots were washed
three times with TBS-T, and the bound antibody was detected on x-ray film by enhanced chemiluminescence with horseradish
peroxidase-conjugated anti-rabbit IgG antibody and cyclic
diacylhydrazides (Amersham).
Materials.
[1-14C]Tetraethylammonium
bromide (185.0 MBq/mmol) was obtained from Du Pont-New England Nuclear
Research Products (Boston, MA). Cimetidine, quinidine sulfate,
tetraethylammonium bromide, guanidine hydrochloride, HEPES and MES were
purchased from Nacalai Tesque Inc. (Kyoto, Japan), and
1-methyl-4-phenylpyridinium iodide was from Research Biochemicals
International (Natick, MA). (
)-Nicotine hydrogen tartate salt and
N1-methylnicotinamide iodide were purchased from Sigma
Chemical Co. (St. Louis, MO). Cephalexin was a gift from Shionogi and
Co. (Osaka, Japan). All other chemicals were of the highest purity available.
| |
Results |
|---|
|
|
|---|
When cultured on a solid matrix, MDCK cells derived from the
canine kidney develop epithelial features such as asymmetric localization of membrane proteins and vectorial transport of various solutes (Handler et al., 1980
). We introduced rat OCT1- and
OCT2-cDNAs into MDCK cells by calcium phosphate coprecipitation as
described in "Methods." Seven and eight G418-resistant clones from
the cells transfected with OCT1- and OCT2-cDNA, respectively, were
selected for further evaluation of
[14C]tetraethylammonium uptake activity. When
tetraethylammonium was added to the medium on the basolateral side, its
accumulation into the cells transfected with OCT1- and OCT2-cDNAs was
markedly elevated compared to that of control cells transfected with
pBK-CMV (MDCK-pBK cells). In addition, the basolateral uptake of
tetraethylammonium by all clones was markedly higher than the apical
uptake (14- to 87-fold and 10- to 98-fold higher for the basolateral
uptake than the apical uptake by the cells transfected with OCT1- and OCT2-cDNAs, respectively), suggesting that both rat OCT1 and OCT2 transporters are expressed in the basolateral membranes of these transfectants. Among these clones, single cells retaining growth rate
and morphological features of MDCK cells were selected and named
MDCK-OCT1 and MDCK-OCT2, respectively.
Figure 1 shows RT-PCR detection of mRNAs
encoding rat OCT1 and OCT2 in rat organs and the transfectants. OCT1
mRNA was expressed in the rat liver, kidney and MDCK-OCT1 cells,
although OCT2 mRNA was expressed only in the kidney and MDCK-OCT2
cells. Tissue distributions of mRNAs encoding rat OCT1 and OCT2 were
comparable to those reported by Gründemann et al.
(1994)
and Okuda et al. (1996)
, respectively.
|
The time courses of tetraethylammonium accumulation by MDCK-OCT1 and MDCK-OCT2 cells were measured. When added to the basolateral medium, tetraethylammonium accumulation by MDCK-OCT1 and MDCK-OCT2 cells was markedly elevated compared to MDCK-pBK cells (fig. 2). However, when tetraethylammonium was added to the apical medium, its accumulation by MDCK-OCT1 and MDCK-OCT2 cells was only slightly elevated or did not change, respectively, compared to the control MDCK-pBK cells. These results suggest that both OCT1 and OCT2 are functionally expressed in the basolateral membranes but not in the apical membranes of these transfectants. In this experiment, radioactivity in the medium on the opposite side (transcellular transport) was minimal or absent for MDCK-OCT1 or MDCK-OCT2 cells, respectively, suggesting that the transport of tetraethylammonium across the apical membranes is negligible (data not shown).
|
To examine the pH dependence of tetraethylammonium transport by OCT1 and OCT2, monolayers of MDCK-OCT1 and MDCK-OCT2 cells were exposed for 15 min to medium at various pHs containing tetraethylammonium on the basolateral side. As shown in figure 3, tetraethylammonium uptake via the basolateral membranes was decreased in accordance with decreases in pH from 8.4 to 5.4. Furthermore, the effects of pH on the efflux of tetraethylammonium from MDCK-OCT1 and MDCK-OCT2 cells were examined (fig. 4). Cells were incubated for 15 min with [14C]tetraethylammonium on the basolateral side, and then the media on both sides were replaced with fresh incubation media (without [14C]tetraethylammonium). Radioactivity remaining in the cells after 5 min incubation was determined. As shown in figure 4, tetraethylammonium efflux from the cells was not affected by the external pH (5.4-8.4), suggesting that extrusion of tetraethylammonium from MDCK-OCT1 and MDCK-OCT2 cells is not pH dependent.
|
|
Next, we examined the concentration dependence of tetraethylammonium uptake by MDCK-OCT1 and MDCK-OCT2 cells (fig. 5). The transfectants were exposed to various concentrations of tetraethylammonium (0.01-1 mM) for 5 min from the basolateral side, then radioactivity in the cells was determined. Tetraethylammonium uptake across the basolateral membranes of MDCK-OCT1 and MDCK-OCT2 cells was saturated at high concentrations. Kinetic parameters were calculated using the Michaelis-Menten equation, and apparent Km values for tetraethylammonium uptake by MDCK-OCT1 and MDCK-OCT2 cells were 38 and 45 µM, respectively. Eadie-Hofstee plots (insets of fig. 5) for these experiments were linear, suggesting that a single transport system for each transfectant was involved in tetraethylammonium uptake.
|
To examine the characteristics of substrate recognition, the effects of
various compounds on tetraethylammonium uptake by MDCK-OCT1 and
MDCK-OCT2 cells were examined. Accumulation of tetraethylammonium by
both MDCK-OCT1 and MDCK-OCT2 cells for 15 min was measured in the
presence of various concentrations of organic cations. As shown in
figure 6, all organic cations inhibited
tetraethylammonium uptake by MDCK-OCT1 and MDCK-OCT2 cells. In
contrast, the inhibitory effect of cephalexin, a zwitterionic compound
that is secreted from renal tubules, on tetraethylammonium uptake by
MDCK-OCT1 or MDCK-OCT2 cells was minimal, suggesting that both OCT1 and OCT2 recognize a wide variety of cationic charged molecules. Inhibitory potencies of organic cations were in the order of
1-methyl-4-phenylpyridinium > cimetidine
quinidine > tetraethylammonium
nicotine > N1-methylnicotinamide
guanidine. Inhibition constants
(Ki) of these compounds against
tetraethylammonium uptake by MDCK-OCT1 and MDCK-OCT2 cells were
calculated and are summarized in table 1.
The Ki values for each compound were comparable
between MDCK-OCT1 and MDCK-OCT2 cells.
|
|
Furthermore, we examined membrane localization of rat OCT1 using a polyclonal antibody against rat OCT1. Figure 7 shows the membrane localization of OCT1 in the brush-border and basolateral membranes of rat kidney cortex and medulla. When blots were incubated with affinity-purified antibody against rat OCT1 polypeptide, an immunoreactive protein with an apparent molecular mass of ~66 kDa was detected at high levels in the basolateral membranes of the rat kidney cortex and a weak band was observed in those of the kidney medulla, but no immunoreactive band was detected in the brush-border membranes (fig. 7A). These immunoreactive bands were completely abolished when the antibody was preabsorbed with OCT1 antigen peptide (1.0 µg/ml) (fig. 7B).
|
| |
Discussion |
|---|
|
|
|---|
In this study, we constructed MDCK transfectants expressing rat OCT1 or OCT2 to clarify the functional characteristics of these transporters. Our results indicated that rat OCT1 is a basolateral organic cation transporter in the rat kidney, and that rat OCT2 is also a basolateral-type organic cation transporter, mediating tubular secretion of various organic cations.
Stimulation of transport function by the proton gradient is the most
critical feature of the H+/organic cation antiporter
localized in the brush-border membranes, but not of the basolateral
organic cation transporter. In our previous studies, tetraethylammonium
uptake by renal brush-border membrane vesicles was shown to be
stimulated by the proton gradient (Takano et al., 1984
), and
extrusive transport of tetraethylammonium from kidney epithelial cells
across apical membranes was markedly stimulated by lowering apical pH
(Saito et al., 1992
). However, little is known about the
effects of pH on the basolateral transport of organic cations.
Previously, we examined the effects of pH on tetraethylammonium uptake
via basolateral membranes of LLC-PK1 cells (Inui and Saito,
1992
). The basolateral uptake of tetraethylammonium was decreased by
lowering basolateral or intracellular pH, suggesting that the
basolateral organic cation transporter is regulated by environmental
pH, but not by a pH-gradient across the basolateral membranes of
LLC-PK1 cells. Recently, Kim and Dantzler (1997)
also
reported that tetraethylammonium uptake across basolateral membranes of
snake renal tubules is inhibited by acidification of the basolateral
medium. In our study, tetraethylammonium uptake via basolateral
membranes of MDCK-OCT1 and MDCK-OCT2 cells was inhibited by lowering
the pH of the medium (fig. 3). However, efflux of tetraethylammonium
from these transfectants was not affected by the pH of the basolateral
medium. These results suggest that transport functions of neither OCT1
nor OCT2 are stimulated by the proton gradient, but rather they are
regulated by environmental pH. Furthermore, in studies using
Xenopus laevis oocytes, decreasing transmembrane electrical
potential by displacement of sodium ions with potassium ions resulted
in decreased accumulation of tetraethylammonium in oocytes injected
with either OCT1 RNA (Gründemann et al., 1994
) or OCT2
RNA (uptake of 64.4 ± 7.4 pmol/oocyte/hr for low potassium buffer
with 101 mM Na+ and 1 mM K+ decreased to uptake
of 44.5 ± 1.0 pmol/oocyte/hr for high potassium buffer with 2 mM
Na+ and 100 mM K+) (M. Okuda, Y. Urakami, H. Saito and K.-I. Inni, unpublished observation). These
results suggest that the driving force for the tetraethylammonium
transport by OCT1 and OCT2 is not the pH gradient but the transmembrane
electrical potential. We speculate that OCTs themselves and/or certain
environmental factor(s) might be regulated by pH, although the precise
mechanisms remain to be determined.
In general, substrate specificities of the brush-border and the
basolateral organic cation transporters are similar, but not identical.
David et al. (1995)
reported that cationic molecules with
low hydrophobicity and low basicity interact with basolateral organic
cation transport systems more strongly than that in the brush-border
membranes. In this study, we analyzed inhibitory potencies of several
organic cations that are known to be secreted into the urine across
renal tubular epithelial cells. The order of inhibitory potencies of
various organic cations on tetraethylammonium uptake by OCT1 and OCT2
was comparable to that on N1-methylnicotinamide uptake
across basolateral membranes, rather than that on
1-methyl-4-phenylpyridinium uptake across brush-border membranes of rat
renal tubules (David et al., 1995
). These results support
the interpretation that both OCT1 and OCT2 are basolateral-type organic
cation transporters, mediating accumulation of organic cations in the kidney.
Recently, Gründemann et al. (1997)
reported cDNA
cloning of the porcine organic cation transporter, OCT2p, from the
renal epithelial cell line LLC-PK1. They investigated the
transport characteristics of OCT2p using several organic compounds as
inhibitors of tetraethylammonium uptake. By comparing the order of
inhibitory potencies of several organic compounds on cellular
accumulation of tetraethylammonium between OCT2p-transfected cells and
LLC-PK1 cells from the apical side, they speculated that
OCT2p is an apical organic cation transporter expressed in
LLC-PK1 cells. In contrast, we found that rat OCT2 is a
basolateral-type organic cation transporter based on the following
evidence. First, the driving force for tetraethylammonium transport by
rat OCT2 was similar to that for the basolateral organic cation
transporter. Tetraethylammonium efflux from MDCK-OCT2 cells was not
proton gradient dependent, and tetraethylammonium uptake by OCT2
RNA-injected oocytes was inhibited by decreasing the transmembrane
electrical potential. These results were similar to those for rat OCT1,
expression of which was shown immunologically to be dominant in the
basolateral membranes rather than brush-border membranes (fig. 7).
Second, when rat OCT1 and OCT2 cDNAs were introduced in MDCK cells,
both OCT1 and OCT2 were functionally expressed in the basolateral
membranes. Third, the specificities of substrate affinity for rat OCT1
and OCT2 were comparable to those observed for the basolateral
membranes of rat renal tubules (David et al., 1995
).
Although Gründemann et al. (1997)
deduced that OCT2p
is the porcine homologue of rat OCT2, we speculated that OCT2p is
another member of the OCT family. It is also possible that there are
species-related differences between rat OCT2 and porcine OCT2p.
Recently, Gorboulev et al. (1997)
reported the
membrane localization of the human isoform of OCT2 (hOCT2) in the
brush-border membranes of distal tubules by immunological staining.
They used anti-rat OCT1 antibody, raised against a partial rat OCT1
amino acid sequence, to detect hOCT2 protein in the kidney. As the
corresponding amino acid sequence of hOCT2 is not identical to that of
rat OCT1, their results may merely indicate the presence of
immunoreactive material in the brush-border membranes of human distal tubules.
As reported previously (Okuda et al., 1996
), the level
of mRNA encoding OCT2 was greater in the medulla than in the cortex, although the level of expression of OCT1 mRNA was greater in the cortex
than in the medulla (Gründemann et al., 1994
).
However, the transport characteristics of OCT1 and OCT2 are similar.
This raises the question of why these two similar transporters are expressed in the kidney. One possibility is that there are differences in the regulation of transport activity between rat OCT1 and OCT2. However, we propose another possibility as follows. Removal of toxic or
unnecessary cationic compounds in the body is critical for defense
against their harmful effects. Recently, it has become clear that
mutations in the transporter genes result in serious diseases such as
malabsorption of glucose in the intestine (Turk et al.,
1991
) and defects in biliary excretion of bilirubin in the liver
(Paulusma et al., 1996
). OCT1 and OCT2 may compensate for
each other under conditions of transporter dysfunction.
In conclusion, we studied the transport characteristics and membrane localization of the rat organic cation transporters OCT1 and OCT2. Our results indicated that both rat OCT1 and OCT2 are basolateral-type organic cation transporters with broad substrate specificities, and contribute to the extrusion of cationic drugs from blood into the urine.
| |
Footnotes |
|---|
Accepted for publication June 16, 1998.
Received for publication February 12, 1998.
1 This work was supported by a Grant-in-Aid for Scientific Research (B) and a Grant-in-Aid for Scientific Research on Priority Areas of "Channel-Transporter Correlation" from the Ministry of Education, Science, and Culture of Japan, and by Grants-in-Aid from the Yamada Science Foundation.
Send reprint requests to: Professor Ken-ichi Inui, Department of Pharmacy, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507, Japan.
| |
Abbreviations |
|---|
RT-PCR, reverse-transcription-polymerase chain reaction; Tris, 2-amino-2-hydroxymethyl-1,3-propanediol; MES, 2-(N-morpholino)ethanesulfonic acid; HEPES, 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
| |
References |
|---|
|
|
|---|
pH studies.
J Pharmacol Exp Ther
216:
294-298
-lactam antibiotics in the intestine and kidney.
J Pharmacol Exp Ther
275:
1631-1637This article has been cited by other articles:
![]() |
K.-i. Umehara, M. Iwai, Y. Adachi, T. Iwatsubo, T. Usui, and H. Kamimura Hepatic Uptake and Excretion of (-)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, in Rats and Humans Drug Metab. Dispos., June 1, 2008; 36(6): 1030 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhou, L. Xia, and J. Wang Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine Drug Metab. Dispos., October 1, 2007; 35(10): 1956 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xia, K. Engel, M. Zhou, and J. Wang Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells Am J Physiol Renal Physiol, February 1, 2007; 292(2): F682 - F690. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-y. Ohta, K. Inoue, Y. Hayashi, and H. Yuasa Molecular Identification and Functional Characterization of Rat Multidrug and Toxin Extrusion Type Transporter 1 as an Organic Cation/H+ Antiporter in the Kidney Drug Metab. Dispos., November 1, 2006; 34(11): 1868 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alnouti, J. S. Petrick, and C. D. Klaassen TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE Drug Metab. Dispos., March 1, 2006; 34(3): 477 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Engel and J. Wang Interaction of Organic Cations with a Newly Identified Plasma Membrane Monoamine Transporter Mol. Pharmacol., November 1, 2005; 68(5): 1397 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishiguro, A. Saito, K. Yokoyama, M. Morikawa, T. Igarashi, and I. Tamai TRANSPORT OF THE DOPAMINE D2 AGONIST PRAMIPEXOLE BY RAT ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 IN KIDNEY Drug Metab. Dispos., April 1, 2005; 33(4): 495 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hukkanen, P. Jacob III, and N. L. Benowitz Metabolism and Disposition Kinetics of Nicotine Pharmacol. Rev., March 1, 2005; 57(1): 79 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Hoffmaster, M. J. Zamek-Gliszczynski, G. M. Pollack, and K. L. R. Brouwer MULTIPLE TRANSPORT SYSTEMS MEDIATE THE HEPATIC UPTAKE AND BILIARY EXCRETION OF THE METABOLICALLY STABLE OPIOID PEPTIDE [D-PENICILLAMINE2,5]ENKEPHALIN Drug Metab. Dispos., February 1, 2005; 33(2): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Miakotina, M. Agassandian, L. Shi, D. C. Look, and R. K. Mallampalli Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2 Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L93 - L102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Thomas, C. Tikellis, P. Kantharidis, W. C. Burns, M. E. Cooper, and J. M. Forbes The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 456 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Grover, D. Buckley, A. R. Buckley, and W. Cacini Reduced Expression of Organic Cation Transporters rOCT1 and rOCT2 in Experimental Diabetes J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 949 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Jonker and A. H. Schinkel Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3) J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 2 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaewmokul, V. Chatsudthipong, K. K. Evans, W. H. Dantzler, and S. H. Wright Functional mapping of rbOCT1 and rbOCT2 activity in the S2 segment of rabbit proximal tubule Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1149 - F1159. [Abstract] [Full Text] |
||||
![]() |
J. W. Jonker, E. Wagenaar, S. van Eijl, and A. H. Schinkel Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations Mol. Cell. Biol., November 1, 2003; 23(21): 7902 - 7908. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of Drug Transporter Studies on Drug Discovery and Development Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Van Bambeke, J.-M. Michot, and P. M. Tulkens Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics J. Antimicrob. Chemother., May 1, 2003; 51(5): 1067 - 1077. [Full Text] [PDF] |
||||
![]() |
B. C. Burckhardt, S. Brai, S. Wallis, W. Krick, N. A. Wolff, and G. Burckhardt Transport of cimetidine by flounder and human renal organic anion transporter 1 Am J Physiol Renal Physiol, March 1, 2003; 284(3): F503 - F509. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Goralski, G. Lou, M. T. Prowse, V. Gorboulev, C. Volk, H. Koepsell, and D. S. Sitar The Cation Transporters rOCT1 and rOCT2 Interact with Bicarbonate but Play Only a Minor Role for Amantadine Uptake into Rat Renal Proximal Tubules J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 959 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Wang, J. W. Jonker, Y. Kato, H. Kusuhara, A. H. Schinkel, and Y. Sugiyama Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 510 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fukada, H. Saito, and K.-i. Inui Transport Mechanisms of Nicotine across the Human Intestinal Epithelial Cell Line Caco-2 J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 532 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Urakami, M. Akazawa, H. Saito, M. Okuda, and K.-i. Inui cDNA Cloning, Functional Characterization, and Tissue Distribution of an Alternatively Spliced Variant of Organic Cation Transporter hOCT2 Predominantly Expressed in the Human Kidney J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1703 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cova, U. Laforenza, G. Gastaldi, Y. Sambuy, S. Tritto, A. Faelli, and U. Ventura Guanidine Transport across the Apical and Basolateral Membranes of Human Intestinal Caco-2 Cells Is Mediated by Two Different Mechanisms J. Nutr., July 1, 2002; 132(7): 1995 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, K. K. Evans, and S. H. Wright Molecular cloning of rabbit organic cation transporter rbOCT2 and functional comparisons with rbOCT1 Am J Physiol Renal Physiol, July 1, 2002; 283(1): F124 - F133. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Motohashi, Y. Sakurai, H. Saito, S. Masuda, Y. Urakami, M. Goto, A. Fukatsu, O. Ogawa, and K.-i. Inui Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney J. Am. Soc. Nephrol., April 1, 2002; 13(4): 866 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer, and C. D. Klaassen Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels Drug Metab. Dispos., February 1, 2002; 30(2): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hill, T. Cihlar, C. Oo, E. S. Ho, K. Prior, H. Wiltshire, J. Barrett, B. Liu, and P. Ward The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion---Correlation of in Vivo and in Vitro Studies Drug Metab. Dispos., January 1, 2002; 30(1): 13 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Sweet, D. S. Miller, and J. B. Pritchard Ventricular Choline Transport. A ROLE FOR ORGANIC CATION TRANSPORTER 2 EXPRESSED IN CHOROID PLEXUS J. Biol. Chem., November 2, 2001; 276(45): 41611 - 41619. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shu, C. L. Bello, L. M. Mangravite, B. Feng, and K. M. Giacomini Functional Characteristics and Steroid Hormone-Mediated Regulation of an Organic Cation Transporter in Madin-Darby Canine Kidney Cells J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 392 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Arndt, C. Volk, V. Gorboulev, T. Budiman, C. Popp, I. Ulzheimer-Teuber, A. Akhoundova, S. Koppatz, E. Bamberg, G. Nagel, et al. Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1 Am J Physiol Renal Physiol, September 1, 2001; 281(3): F454 - F468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Jonker, E. Wagenaar, C. A. A. M. Mol, M. Buitelaar, H. Koepsell, J. W. Smit, and A. H. Schinkel Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene Mol. Cell. Biol., August 15, 2001; 21(16): 5471 - 5477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Chen, Z. Li, H. Pan, D. L. Murphy, H. Tamir, H. Koepsell, and M. D. Gershon Maintenance of Serotonin in the Intestinal Mucosa and Ganglia of Mice that Lack the High-Affinity Serotonin Transporter: Abnormal Intestinal Motility and the Expression of Cation Transporters J. Neurosci., August 15, 2001; 21(16): 6348 - 6361. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Han, D. H. Sweet, D.-N. Hu, and J. B. Pritchard Characterization of a Novel Cationic Drug Transporter in Human Retinal Pigment Epithelial Cells J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 450 - 457. [Abstract] [Full Text] |
||||
![]() |
D. H. Sweet, D. S. Miller, and J. B. Pritchard Basolateral localization of organic cation transporter 2 in intact renal proximal tubules Am J Physiol Renal Physiol, November 1, 2000; 279(5): F826 - F834. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Terada, K. Sawada, T. Ito, H. Saito, Y. Hashimoto, and K.-I. Inui Functional expression of novel peptide transporter in renal basolateral membranes Am J Physiol Renal Physiol, November 1, 2000; 279(5): F851 - F857. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Karbach, J. Kricke, F. Meyer-Wentrup, V. Gorboulev, C. Volk, D. Loffing-Cueni, B. Kaissling, S. Bachmann, and H. Koepsell Localization of organic cation transporters OCT1 and OCT2 in rat kidney Am J Physiol Renal Physiol, October 1, 2000; 279(4): F679 - F687. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Burckhardt and N. A. Wolff Structure of renal organic anion and cation transporters Am J Physiol Renal Physiol, June 1, 2000; 278(6): F853 - F866. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ueda, Y. Horibe, K.-J. Kim, and V. H. L. Lee Functional Characterization of Organic Cation Drug Transport in the Pigmented Rabbit Conjunctiva Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 870 - 876. [Abstract] [Full Text] |
||||
![]() |
D. H. Sweet and J. B. Pritchard rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger Am J Physiol Renal Physiol, December 1, 1999; 277(6): F890 - F898. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, W. Huang, P. D. Prasad, P. Seth, D. P. Rajan, F. H. Leibach, J. Chen, S. J. Conway, and V. Ganapathy Functional Characteristics and Tissue Distribution Pattern of Organic Cation Transporter 2 (OCTN2), an Organic Cation/Carnitine Transporter J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1482 - 1492. [Abstract] [Full Text] |
||||
![]() |
K. B. Goralski and D. S. Sitar Tetraethylammonium and Amantadine Identify Distinct Organic Cation Transporters in Rat Renal Cortical Proximal and Distal Tubules J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 295 - 302. [Abstract] [Full Text] |
||||
![]() |
D. Gründemann, G. Liebich, N. Kiefer, S. Köster, and E. Schömig Selective Substrates for Non-Neuronal Monoamine Transporters Mol. Pharmacol., July 1, 1999; 56(1): 1 - 10. [Abstract] [Full Text] |
||||
![]() |
T. Budiman, E. Bamberg, H. Koepsell, and G. Nagel Mechanism of Electrogenic Cation Transport by the Cloned Organic Cation Transporter 2 from Rat J. Biol. Chem., September 15, 2000; 275(38): 29413 - 29420. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||